PALNAT-125 MG
Prescription Required
Sale price
₹ 2,500.00
Regular price
MRP: ₹ 4,218.75
41% OFF
Inclusive of all taxes.
Couldn't load pickup availability
PALNAT-125 MG
Regular price
₹ 2,500.00
Regular price
₹ 4,218.75
Sale price
₹ 2,500.00
(-41%)
Unit price
per
PALNAT-125 MG
Sale price
₹ 2,500.00
Regular price
MRP: ₹ 4,218.75
41% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Palnat 125mg Capsule contains palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor that slows the growth of hormone receptor-positive breast cancer cells.
Uses
Palnat 125mg Capsule is used with endocrine therapy for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
- HR-positive, HER2-negative advanced breast cancer
- Metastatic breast cancer
Storage
- Store below 30°C.
- Keep in a cool, dry place away from moisture.
Safety Information
- Monitor complete blood counts regularly during treatment.
- Avoid grapefruit products unless advised by your doctor.
Possible Side Effects
Possible side effects may include:
- Neutropenia
- Fatigue
- Nausea
- Stomatitis
- Infections
- Hair thinning
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Palnat is a prescription targeted anticancer medicine.
It should only be used under the supervision of a qualified oncologist.